SPRINGWORKS THERAPEUTICS, INC. - Common Stock, par value $.0001 per share (SWTX)

Q: What does CUSIP 85205L107 represent in this 13F holders report?

CUSIP 85205L107 is the security identifier for SWTX - SPRINGWORKS THERAPEUTICS, INC. - Common Stock, par value $.0001 per share used to aggregate holder disclosures.

Q: How many institutions held SWTX - SPRINGWORKS THERAPEUTICS, INC. - Common Stock, par value $.0001 per share in Q2 2021?

133 institutional investors reported SWTX - SPRINGWORKS THERAPEUTICS, INC. - Common Stock, par value $.0001 per share for Q2 2021. Use the holders table for investor-level position and value details.

CUSIP: 85205L107

Q2 2021 13F Holders as of 30 Jun 2021

Type / Class: Equity / Common Stock, par value $.0001 per share
Shares outstanding: 75,607,738
Total 13F shares: 44,740,163
Share change: +846,258
Total reported value: $3,687,111,174
Price per share: $82.41
Number of holders: 133
Value change: +$75,214,918
Number of buys: 77
Number of sells: 56

Quarterly Holders Quick Answers

What is CUSIP 85205L107?
CUSIP 85205L107 identifies SWTX - SPRINGWORKS THERAPEUTICS, INC. - Common Stock, par value $.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2021
Previous quarter: Q1 2021

Recent filing periods for CUSIP 85205L107:

Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024

Top shareholders of SWTX - SPRINGWORKS THERAPEUTICS, INC. - Common Stock, par value $.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
ORBIMED ADVISORS LLC	13F	Company	8.2%	6,186,307	$455,127,000	—	31 Mar 2021	13F
Bain Capital Life Sciences Investors, LLC	13F	Company	7.7%	5,831,307	$429,009,000	—	31 Mar 2021	13F
PERCEPTIVE ADVISORS LLC	13F	Company	6.4%	4,849,912	$356,808,000	—	31 Mar 2021	13F
FMR LLC	13F	Company	5%	3,791,368	$278,931,000	—	31 Mar 2021	13F
VANGUARD GROUP INC	13F	Company	3.3%	2,494,056	$183,487,000	—	31 Mar 2021	13F
BlackRock Finance, Inc.	13F	Company	3%	2,269,538	$166,969,000	—	31 Mar 2021	13F
Boxer Capital, LLC	13F	Company	2.7%	2,075,905	$152,724,000	—	31 Mar 2021	13F
DRIEHAUS CAPITAL MANAGEMENT LLC	13F	Company	1.7%	1,262,075	$92,851,000	—	31 Mar 2021	13F
Consonance Capital Management LP	13F	Company	1.6%	1,201,399	$88,387,000	—	31 Mar 2021	13F
ArrowMark Colorado Holdings LLC	13F	Company	1.5%	1,144,604	$84,209,000	—	31 Mar 2021	13F
STATE STREET CORP	13F	Company	1.4%	1,079,568	$79,424,000	—	31 Mar 2021	13F
VICTORY CAPITAL MANAGEMENT INC	13F	Company	1.1%	845,265	$62,187,000	—	31 Mar 2021	13F
CITADEL ADVISORS LLC	13F	Company	1.1%	801,391	$58,958,000	—	31 Mar 2021	13F
PICTET ASSET MANAGEMENT LTD	13F	Company	0.99%	745,235	$54,827,000	—	31 Mar 2021	13F
LOOMIS SAYLES & CO L P	13F	Company	0.76%	577,032	$42,452,000	—	31 Mar 2021	13F
ADAGE CAPITAL PARTNERS GP, L.L.C.	13F	Company	0.75%	567,935	$41,783,000	—	31 Mar 2021	13F
DEERFIELD MANAGEMENT COMPANY, L.P.	13F	Company	0.74%	558,574	$41,094,000	—	31 Mar 2021	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.66%	500,553	$36,826,000	—	31 Mar 2021	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.59%	448,134	$32,969,000	—	31 Mar 2021	13F
NORGES BANK	13F	Company	0.58%	436,335	$32,101,000	—	31 Mar 2021	13F
Artal Group S.A.	13F	Company	0.53%	400,000	$29,428,000	—	31 Mar 2021	13F
MASSACHUSETTS FINANCIAL SERVICES CO /MA/	13F	Company	0.52%	393,989	$28,986,000	—	31 Mar 2021	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	0.43%	327,679	$24,107,000	—	31 Mar 2021	13F
NORTHERN TRUST CORP	13F	Company	0.39%	295,925	$21,772,000	—	31 Mar 2021	13F
BESSEMER GROUP INC	13F	Company	0.38%	286,337	$21,066,000	—	31 Mar 2021	13F
CAAS CAPITAL MANAGEMENT LP	13F	Company	0.3%	224,886	$16,545,000	—	31 Mar 2021	13F
Laurion Capital Management LP	13F	Company	0.29%	218,266	$16,058,000	—	31 Mar 2021	13F
AMERIPRISE FINANCIAL INC	13F	Company	0.25%	192,660	$14,174,000	—	31 Mar 2021	13F
JENNISON ASSOCIATES LLC	13F	Company	0.24%	185,085	$13,617,000	—	31 Mar 2021	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.24%	179,786	$13,227,000	—	31 Mar 2021	13F
Woodline Partners LP	13F	Company	0.23%	175,328	$12,899,000	—	31 Mar 2021	13F
Samsara BioCapital, LLC	13F	Company	0.22%	169,852	$12,496,000	—	31 Mar 2021	13F
D. E. Shaw & Co., Inc.	13F	Company	0.2%	150,241	$11,053,000	—	31 Mar 2021	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.19%	139,987	$10,299,000	—	31 Mar 2021	13F
SPHERA FUNDS MANAGEMENT LTD.	13F	Company	0.18%	137,672	$10,129,000	—	31 Mar 2021	13F
MORGAN STANLEY	13F	Company	0.18%	133,866	$9,849,000	—	31 Mar 2021	13F
S.c.a. Candriam	13F	Individual	0.18%	135,879	$9,466,000	—	31 Mar 2021	13F
Cormorant Asset Management, LP	13F	Company	0.17%	125,000	$9,196,000	—	31 Mar 2021	13F
AXA S.A.	13F	Company	0.15%	111,709	$8,218,000	—	31 Mar 2021	13F
CIBC Asset Management Inc	13F	Company	0.14%	106,503	$7,835,000	—	31 Mar 2021	13F
TCW GROUP INC	13F	Company	0.13%	100,168	$7,370,000	—	31 Mar 2021	13F
Invesco Ltd.	13F	Company	0.13%	97,993	$7,209,000	—	31 Mar 2021	13F
CASTLEARK MANAGEMENT LLC	13F	Company	0.12%	93,956	$6,912,000	—	31 Mar 2021	13F
Nuveen Asset Management, LLC	13F	Company	0.12%	93,000	$6,842,000	—	31 Mar 2021	13F
Bank of New York Mellon Corp	13F	Company	0.12%	89,990	$6,620,000	—	31 Mar 2021	13F
ALPS ADVISORS INC	13F	Company	0.12%	88,231	$6,491,000	—	31 Mar 2021	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.1%	77,990	$5,738,000	—	31 Mar 2021	13F
DEUTSCHE BANK AG\	13F	Company	0.09%	67,504	$4,966,000	—	31 Mar 2021	13F
MARSHALL WACE, LLP	13F	Company	0.09%	65,044	$4,785,000	—	31 Mar 2021	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.08%	60,900	$4,480,000	—	31 Mar 2021	13F

Institutional Holders of SPRINGWORKS THERAPEUTICS, INC. - Common Stock, par value $.0001 per share (SWTX) as of Q2 2021

As of 30 Jun 2021, SPRINGWORKS THERAPEUTICS, INC. - Common Stock, par value $.0001 per share (SWTX) was held by 133 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 44,740,163 shares. The largest 10 holders included ORBIMED ADVISORS LLC, Bain Capital Life Sciences Investors, LLC, PERCEPTIVE ADVISORS LLC, FMR LLC, VANGUARD GROUP INC, BlackRock Inc., BOXER CAPITAL, LLC, DRIEHAUS CAPITAL MANAGEMENT LLC, Consonance Capital Management LP, and ArrowMark Colorado Holdings LLC. This page lists 133 institutional shareholders reporting positions in this security for the Q2 2021 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2021 vs Q1 2021 Across Filers

Q1 2021 holders

135

Q2 2021 holders

133

Holder diff

-2

Investor	Q1 2021 Shares	Q2 2021 Shares	Share Diff	Share Chg %	Q1 2021 Value $	Q2 2021 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.